USD $73.50
IndiaReyvow (Lasmiditan) is a prescription medication used for the acute treatment of migraine attacks in adults. It is designed to provide relief from migraine symptoms without the vasoconstrictive effects associated with traditional migraine treatments.
The recommended dose of Reyvow is 100 mg, taken orally as needed for the acute treatment of migraine. If a patient's migraine returns, a second dose may be taken after 2 hours, but do not exceed 200 mg in a 24-hour period. It is important to follow your healthcare provider's instructions regarding dosage.
Common side effects of Reyvow may include:
Serious side effects can occur. If you experience symptoms such as chest pain, difficulty breathing, or severe allergic reactions, seek medical attention immediately.
Avoid driving or operating heavy machinery until you know how Reyvow affects you, as it may cause drowsiness.
Reyvow is not suitable for individuals with a history of hypersensitivity to Lasmiditan or for those with certain cardiovascular conditions. Always consult with your healthcare provider before starting any new medication.
Reyvow is intended for the acute treatment of migraine attacks, not for the prevention of chronic migraines. Discuss with your healthcare provider for appropriate preventive treatments.
